Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Hearing and COMT[original query] |
---|
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nature genetics 2009 Dec 41 (12): 1345-9. Ross Colin J D, Katzov-Eckert Hagit, Dubé Marie-Pierre, Brooks Beth, Rassekh S Rod, Barhdadi Amina, Feroz-Zada Yassamin, Visscher Henk, Brown Andrew M K, Rieder Michael J, Rogers Paul C, Phillips Michael S, Carleton Bruce C, Hayden Michael R, |
Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children. Clinical pharmacology and therapeutics 2013 Aug 94 (2): 243-51. Pussegoda K, Ross C J, Visscher H, Yazdanpanah M, Brooks B, Rassekh S R, Zada Y F, Dubé M-P, Carleton B C, Hayden M R, |
Association of Single Nucleotide Polymorphisms in Catechol-O-Methyltransferase and Serine-Threonine Protein Kinase Genes in the Pakistani Schizophrenic Population: A Study with Special Emphasis on Cannabis and Smokeless Tobacco. CNS & neurological disorders drug targets 2015 Mar . Nawaz R, Siddiqui |
Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts. PloS one 2014 9 (12): e115869. Hagleitner Melanie M, Coenen Marieke J H, Patino-Garcia Ana, de Bont Eveline S J M, Gonzalez-Neira Anna, Vos Hanneke I, van Leeuwen Frank N, Gelderblom Hans, Hoogerbrugge Peter M, Guchelaar Henk-Jan, Te Loo Maroeska W |
Genetic risk factors of cisplatin induced ototoxicity in adult patients. Neoplasma 2016 Jan 63 (2): . Talach T, Rottenberg J, Gal B, Kostrica R, Jurajda M, Kocak I, Lakomy R, Vogazianos |
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity. Pharmacogenetics and genomics 2017 Apr . Thiesen Signe, Yin Peng, Jorgensen Andrea L, Zhang Jieying E, Manzo Valentina, McEvoy Laurence, Barton Christopher, Picton Susan, Bailey Simon, Brock Penelope, Vyas Harish, Walker David, Makin Guy, Bandi Srinivas, Pizer Barry, Hawcutt Daniel B, Pirmohamed Mun |
[The analysis of the association of the polymorphic variants of the TPMT, COMT, and ABCC3 genes with the development of hearing disorders induced by the cisplatin treatment]. Vestnik otorinolaringologii 2018 83 (4): 60-66. Mironovich O L, Bliznetz E A, Garbaruk E S, Belogurova M B, Subora N V, Varfolomeeva S R, Kachanov D Yu, Shamanskaya T V, Markova T G, Polyakov A |
COMT and the neurogenetic architecture of hearing loss induced tinnitus. Hearing research 2018 Jun 365 1-15. Vanneste Sven, Alsalman Ola, De Ridder Di |
Effects of COMT polymorphism on the cortical processing of vocal pitch regulation. Neuroreport 2018 Oct . Zhang Siyun, Wang Wenda, Zhang Baofeng, Liu Peng, Liu Hanj |
Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience. Pediatric blood & cancer 2018 1 65 (5): e26931. Soliman Sameh E, D'Silva Crystal N, Dimaras Helen, Dzneladze Irakli, Chan Helen, Gallie Brenda |
Catechol-O-methyltransferase (COMT) Val158Met Polymorphism and Prepulse Inhibition of the Change-related Cerebral Response. Psychiatry research. Neuroimaging 2022 4 323 111484. Motomura Eishi, Tanii Hisashi, Kawano Yasuhiro, Inui Koji, Okada Motohi |
A Missense Variant in COMT Associated with Hearing Loss among Young Adults: The National Longitudinal Study of Adolescent to Adult Health (Add Health). Biomedicines 2022 11 10 (11): . Li Chuan-Ming, Chen Le, Chen Guanjie, Zhang Jianhua, Hoffman Howard |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: